- Syntrix doses first metastatic melanoma patient testing dual inhibotor of CXCR1/2 with Merck’s Keytruda
June 20, 2019 2:33 pm
- Edesa Biotech continues testing potential dermatitis treatment EB01
June 20, 2019 2:13 pm
- Camurs gets FDA’s green light to kick off phase 3 testing of treatment of acromegaly and neuroendocrine tumors
June 20, 2019 2:07 pm
- Axial Biotherapeutics bags $10M Investment from Taiho Ventures to Access Axial’s Expertise in the Gut-Brain Axis
June 20, 2019 2:01 pm
- Elligo Health Research Strengthens Ability to Grow and Enable Physician Practice Clinical Research June 20, 2019 2:00 pm
- Vaxart to Present at ASM Microbe 2019 June 20, 2019 2:00 pm
- Horizon Therapeutics evaluates Krystexxa in combination with methotrexate to increase response rates and duration of therapy
June 20, 2019 2:00 pm
- Cancer Prevention Pharmaceuticals (CPP) FAP Phase 3 Trial doesn’t show statistical significance in outperforming the single agents
June 20, 2019 2:00 pm
- Cyxone starts in-human testing of its multiple sclerosis drug candidate
June 20, 2019 1:32 pm
- Globally Recognized Nephrologist Joins Dicerna™ to Support Continued Development of DCR-PHXC for the Treatment of Primary Hyperoxaluria June 20, 2019 1:30 pm
- AstraZeneca’s Bevespi Aerosphere approved in Japan for COPD patients
June 20, 2019 1:00 pm
- Verastem Oncology Announces Leadership Changes June 20, 2019 1:00 pm
My Pharmaceutical
Natural ingredients show beneficial effects on cardiovascular health and sports performance
Euromed, a Spain-based producer of standardized herbal extracts and natural active substances for pharmaceutical, nutraceutical and cosmetic industries, said Wednesday that, according to a recently published randomised, double-blind, placebo-controlled study, supplementation with Euromed’s natural extracts Pomanox™ and Mediteanox™ could help to maintain a healthy blood pressure, endothelial function and levels of circulating oxidised low-density lipoprotein cholesterol (oxLDL).
